Clinical Trial

Hemodynamic Response to the End-expiratory Occlusion Test to Titrate Fluid Challenge in Operating Room.

Study acronym: FC_EEOT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Personalzing intraoperative anesthetic fluid management may help in preventing fluid accumulation and related complications. Fluids are gine as boluses in operating room (the so-called FC). The response to the FC is due to several physiological conditions related to the "preload dependency" (i.e. the intrinsic ability of the heart of increasing the stroke volume - SV - in response to fluid administration). The minimal volume required to appropriately "challenge" the cardiovascular system is 4 ml/kg of fluid, but higher volumes (up to 6 ml/kg may be needed). Predicting the response to FC administration may be possible by applying a physiological test (called functional hemodynamic test), such as the end-expiratory occlusion test, consisting in interrupping the mechanical ventilation and hence promoting venous return and consequente SV changes. The percentage of SV increase associated to EEOT may predict fluid responsiveness to the FC (patients responders will increase SV to a bigger extent, as compared to non-responders)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-03.
Trial Details
NCT Number NCT06627907
Lead Sponsor Humanitas Clinical and Research Center
Conditions Fluid Responsiveness Predictability
Enrollment 300 participants
Start Date 2024-11-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-08